Zobrazeno 1 - 7
of 7
pro vyhledávání: '"S. V Luchinina"'
Autor:
S. B. Yatsyshina, M. V. Mamoshina, M. A. Elkina, G. V. Sharukho, Yu. I. Raspopova, А. Ya. Folmer, K. A. Agapov, I. M. Vladimirov, O. V. Zubareva, I. S. Novikova, O. B. Bondareva, V. A. Gil, D. N. Kozlovskikh, S. V. Romanov, O. V. Dikonskaya, A. V. Ponomareva, I. V. Chistyakova, N. I. Kochneva, A. I. Yurovskikh, E. P. Kadnikova, A. S. Kilyachina, S. V. Luchinina, R. R. Kosareva, G. G. Chirkova, N. N. Valeullina, L. A. Lebedeva, T. N. Detkovskaya, E. I. Abbasova, O. B. Romanova, E. V. Pyatyrova, V. G. Akimkin
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 98, Iss 4, Pp 383-396 (2021)
Introduction. SARS-CoV-2 can be transmitted by infected people without or with mild symptoms of acute respira-tory infection (ARI). Monitoring based on nucleic acid amplification techniques is used to measure the prevalence of ARI pathogens and to as
Externí odkaz:
https://doaj.org/article/185eddb95d1c4d48b7c670d829b42299
Autor:
A. Yu. Popova, E. B. Ezhlova, A. A. Melnikova, V. S. Smirnov, L. V. Lyalina, D. N. Kozlovskikh, S. V. Luchinina, S. V. Romanov, N. N. Valeullina, O. V. Dikonskaya, G. G. Chirkova, O. L. Malykh, A. V. Ponomareva, I. V. Chistyakova, A. S. Kilyachina, A. I. Yurovskikh, A. A. Kotova, A. A. Totolian
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 20, Iss 3, Pp 8-18 (2021)
Relevance. At the end of 2019, the world was confronted with a novel coronavirus (SARS-CoV-2), In January 2020, WHO declared an epidemic related to SARS-CoV-2, a health emergency of international importance, and in March characterized the spread of t
Externí odkaz:
https://doaj.org/article/e265836438f647df944f209e362d08e8
Autor:
S. V. Luchinina, A. I. Semenov, O. N. Stepanova, V. V. Pogodina, S. G. Gerasimov, M. S. Shcherbinina, L. I. Kolesnikova, T. A. Suslova
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 15, Iss 1, Pp 67-76 (2016)
The Chelyabinsk Region (Southern Urals) is high endemic territory. The TBE incidence is 3.57 ± 1.7 per 100 000 of population. A level of vaccination against TBE increased from 0.3 to 34.8% in 1999 - 2013. Specific immunity of population in 35.9% is
Externí odkaz:
https://doaj.org/article/d74975f647164ded928f976d075803c0
Autor:
M. A. Elkina, O. V. Zubareva, E. I. Abbasova, N. N. Valeullina, S. B. Yatsyshina, I. M. Vladimirov, K. A. Agapov, D.N. Kozlovskikh, G. G. Chirkova, A. S. Kilyachina, I. V. Chistyakova, O. V. Dikonskaya, Y. I. Raspopova, S. V. Luchinina, G. V. Sharukho, A. Y. Folmer, A. I. Yurovskikh, O. B. Bondareva, V. A. Gil, A. V. Ponomareva, E. P. Kadnikova, Akimkin Vg, T. N. Detkovskaya, M. V. Mamoshina, R. R. Kosareva, L. A. Lebedeva, S. V. Romanov, N. I. Kochneva, I. S. Novikova, E. V. Pyatyrova, O. B. Romanova
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 98, Iss 4, Pp 383-396 (2021)
Introduction . SARS-CoV-2 can be transmitted by infected people without or with mild symptoms of acute respira-tory infection (ARI). Monitoring based on nucleic acid amplification techniques is used to measure the prevalence of ARI pathogens and to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::555c925c0316dde77c27a450f4eb6446
https://microbiol.elpub.ru/jour/article/view/1089
https://microbiol.elpub.ru/jour/article/view/1089
Autor:
N. N. Valeullina, D. N. Kozlovskikh, S. V. Luchinina, A. I. Yurovskikh, Areg A. Totolian, A. A. Kotova, G. G. Chirkova, L. V. Lyalina, A. A. Melnikova, O. L. Malykh, S. V. Romanov, A. S. Kilyachina, E. B. Ezhlova, O. V. Dikonskaya, V. S. Smirnov, A. V. Ponomareva, A. Y. Popova, I. V. Chistyakova
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 20, Iss 3, Pp 8-18 (2021)
Relevance. At the end of 2019, the world was confronted with a novel coronavirus (SARS-CoV-2), In January 2020, WHO declared an epidemic related to SARS-CoV-2, a health emergency of international importance, and in March characterized the spread of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a982b68efaca3b6c514b879672c256a
https://doi.org/10.31631/2073-3046-2021-20-3-8-18
https://doi.org/10.31631/2073-3046-2021-20-3-8-18
Autor:
O. N Stepanova, G. V Malenko, G. G Chirkova, A. N Gorfinkel, Karan' Ls, Levina Ls, V. V. Pogodina, V. Ya Karmysheva, Gerasimov Sg, N. M Kolyasnikova, L. I Kolesnikova, E. A Stenko, S. V Luchinina
Publikováno v:
Epidemiology and Infectious Diseases. 20:56-64
Lethal cases of tick-borne encephalitis in previously vaccinated patients have not been described. Modern inactivated vaccines against Tick-borne encephalitis (TBE) are high effective. The TBE cases, preference unfocal forms, are developed in persons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::174ff7304d60abc728bcc978280e7990
https://doi.org/10.17816/eid40869
https://doi.org/10.17816/eid40869
Publikováno v:
Zhurnal mikrobiologii, epidemiologii i immunobiologii. (5)
Results of the analysis of epizootological and epidemiological situations on avian flu in the Chelyabinsk region in season 2005 are submitted. Features of the foci of the avian flu in the given territory are marked. In particular, the struck settleme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5fbba813ee77be8c4e7810297ec4ae68
https://pubmed.ncbi.nlm.nih.gov/16981505
https://pubmed.ncbi.nlm.nih.gov/16981505